The results increase “my confidence that this approach has merit,” Lauren Sansing says. More trials are on the way.

During an ischemic stroke, blood vessels in the brain are blocked or narrowed. During a hemorrhagic stroke, there's bleeding ...

My neighbor had a stroke and received a "clot buster" medication. Then, I found out my uncle had a surgery after a stroke.

Key measures included the proportion of patients receiving intravenous tissue plasminogen activator (IV tPA), mechanical thrombectomy, time from stroke onset to treatment, and rates of complications ...

Background and Purpose: In the current era, where mechanical thrombectomy (MT) has become the gold standard for treating large vessel occlusions in acute ischemic stroke, the role of intravenous ...

Such patients are likely to have suffered a major artery occlusion, and the probability of successful recanalization with intravenous tPA is low, but they could still be candidates for ...

Although this is true for many people with iron deficiency, it can be much more complicated. When determining which iron therapy—oral or intravenous (IV)—is right for you, it is important to consider ...

Do you love the frantic, breathless scrap for survival of Hotline Miami, desperately seeking cover as enemies close in from all directions? The precise, measured stealth of Splinter Cell, where ...

Patients with acute stroke benefit from thrombolysis with IV tissue plasminogen activator (tPA). In the last decade, a number of endovascular techniques have increasingly been used to open blood ...

The laboratory is leading the charge in developing the next generation of nuclear reactors, known as Gen-IV reactors. These reactors promise to be safer, more efficient and produce less waste than ...

In addition, most patients in CHOICE received IV thrombolytics before the procedure, compared with none in POST-UK and POST-TNK. In that context, these newer data “are promising in terms of a ...

Methods: We retrospectively enrolled patients who received intravenous tissue plasminogen activator (IV-tPA) thrombolysis within 4.5 h after symptom onset to form the original modeling cohort. HT was ...